Why Amphastar's Stock Is Trading Higher Today

Amphastar Pharmaceuticals AMPH shares are trading higher on Monday after Northland Capital Markets upgraded the stock from Market Perform to Outperfrom.

Amphastar is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable and inhalation products. The business activities are operated through two reportable segments namely finished pharmaceutical products and API products.

Amphastar Pharmaceuticals shares traded up 6.32% to $20.20 on Monday. The stock has a 52-week high of $22.69 and a 52-week low of $12.32.

Posted In: why it's movingUpgradesAnalyst Ratings